IDEXX LABORATORIES INC /DE — Director's Dealing 2023

Nov 8, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2023-11-07

Reporting Person: Lane Michael (Executive Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-11-07	Common Stock	M	462	$67.85	Acquired	4507.9875	Direct
2023-11-07	Common Stock	M	706	$141.60	Acquired	5213.9875	Direct
2023-11-07	Common Stock	M	560	$178.26	Acquired	5773.9875	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-11-07	Incentive Stock Option (right-to-buy)	$67.85	M	462	Disposed	2026-02-13	Common Stock (462)	Direct
2023-11-07	Incentive Stock Option (right-to-buy)	$141.60	M	706	Disposed	2027-02-13	Common Stock (706)	Direct
2023-11-07	Incentive Stock Option (right-to-buy)	$178.26	M	560	Disposed	2028-02-13	Common Stock (560)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	592	Indirect

Footnotes

F1: Includes 12 shares purchased under the Issuer's Employee Stock Purchase Plan on September 29, 2023.

F2: Held by the reporting person's spouse in an IRA account. The reporting person disclaims beneficial ownership of the shares of common stock held by his spouse except to the extent of his pecuniary interest therein.

F3: Grant of option to buy 2,072 shares of Issuer common stock that vested as to 1 share on February 14, 2017, February 14, 2018 and February 14, 2020, respectively, and as to the remainder on February 14, 2021.

F4: Grant of option to buy 706 shares of Issuer common stock that vested ion the fifth anniversary of the date of grant.

F5: Grant of option to buy 560 shares of Issuer common stock that vested on the fifth anniversary of the date of grant.